Shukra Pharmaceuticals informs about compliance certificate
Shukra Pharmaceuticals has informed that it enclosed compliance certificate under Regulation 74(5) of (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2025.
The above information is a part of company’s filings submitted to BSE.
